Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma.

Sixty-three new untreated patients with multiple myeloma under the age of 70 years received C-VAMP induction treatment followed by high-dose intravenous melphalan (200 mg m(-2)) and autologous stem cell transplant, either with marrow [autologous bone marrow transplants (ABMT), n = 26] or with granul...

Descripción completa

Detalles Bibliográficos
Autores principales: Raje, N., Powles, R., Horton, C., Millar, B., Shepherd, V., Middleton, G., Kulkarni, S., Eisen, T., Mehta, J., Singhal, S., Treleaven, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223521/
https://www.ncbi.nlm.nih.gov/pubmed/9184187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223521/
https://www.ncbi.nlm.nih.gov/pubmed/9184187

Ejemplares similares